Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impaired IFN-alpha production and the risk of cancer development.
Uno K, Hirosaki M, Kakimi K, Tominaga M, Suginoshita Y, Hasegawa G, Fukui M, Nakamura N, Shirakawa T, Kishida T. Uno K, et al. J Interferon Cytokine Res. 2007 Dec;27(12):1013-7. doi: 10.1089/jir.2007.0047. J Interferon Cytokine Res. 2007. PMID: 18184042
Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study.
Niwamoto T, Handa T, Murase Y, Nakatsuka Y, Tanizawa K, Taguchi Y, Tomioka H, Tomii K, Kita H, Uyama M, Tsuchiya M, Emura M, Kawamura T, Arai N, Arita M, Uno K, Yoshizawa A, Uozumi R, Yamaguchi I, Matsuda F, Chin K, Hirai T. Niwamoto T, et al. Among authors: uno k. Respir Res. 2021 Jun 17;22(1):181. doi: 10.1186/s12931-021-01779-9. Respir Res. 2021. PMID: 34158044 Free PMC article.
Whole blood interferon-γ levels predict the therapeutic effects of adoptive T-cell therapy in patients with advanced pancreatic cancer.
Ishikawa T, Kokura S, Sakamoto N, Okayama T, Endo M, Tsuchiya R, Okajima M, Matsuyama T, Adachi S, Kamada K, Katada K, Uchiyama K, Handa O, Takagi T, Yagi N, Ando T, Uno K, Naito Y, Yoshikawa T. Ishikawa T, et al. Among authors: uno k. Int J Cancer. 2013 Sep 1;133(5):1119-25. doi: 10.1002/ijc.28117. Epub 2013 Mar 29. Int J Cancer. 2013. PMID: 23420507
Phase I clinical trial of fibronectin CH296-stimulated T cell therapy in patients with advanced cancer.
Ishikawa T, Kokura S, Enoki T, Sakamoto N, Okayama T, Ideno M, Mineno J, Uno K, Yoshida N, Kamada K, Katada K, Uchiyama K, Handa O, Takagi T, Konishi H, Yagi N, Naito Y, Itoh Y, Yoshikawa T. Ishikawa T, et al. Among authors: uno k. PLoS One. 2014 Jan 31;9(1):e83786. doi: 10.1371/journal.pone.0083786. eCollection 2014. PLoS One. 2014. PMID: 24497917 Free PMC article. Clinical Trial.
1,184 results